Loading...

IMCD N.V.

IMDZFPNK
Basic Materials
Chemicals - Specialty
$133.20
$0.00(0.00%)

IMCD N.V. (IMDZF) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for IMCD N.V. (IMDZF), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
6.41%
6.41%
Operating Income Growth
-0.80%
0.80%
Net Income Growth
-4.80%
4.80%
Operating Cash Flow Growth
-33.52%
33.52%
Operating Margin
8.99%
8.99%
Gross Margin
25.43%
25.43%
Net Profit Margin
5.89%
5.89%
ROE
14.04%
14.04%
ROIC
11.09%
11.09%

IMCD N.V. (IMDZF) Income Statement & Financial Overview

Explore comprehensive income reports for IMCD N.V. IMDZF, broken down by year and quarter.

MetricQ4 2024Q2 2024Q4 2023Q3 2023
Revenue$2.34B$2.39B$2.16B$1.08B
Cost of Revenue$2.09B$1.78B$1.92B$807.72M
Gross Profit$257.40M$615.64M$232.11M$274.70M
Gross Profit Ratio$0.11$0.26$0.11$0.25
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$56.61M$268.97M$59.15M$123.62M
Operating Expenses$46.21M$395.52M$42.60M$165.60M
Total Costs & Expenses-$2.13B$2.17B$1.97B$973.32M
Interest Income$2.56M$3.10M$33.40M$14.14M
Interest Expense$37.05M$0.00$29.32M$0.00
Depreciation & Amortization$69.73M$66.87M$60.37M$17.33M
EBITDA$293.34M$287.55M$114.43M$114.43M
EBITDA Ratio$0.13$0.12$0.12$0.11
Operating Income$211.19M$220.13M$189.50M$97.10M
Operating Income Ratio$0.09$0.09$0.09$0.09
Other Income/Expenses (Net)-$24.64M-$26.70M-$94.54M-$2.14M
Income Before Tax$186.55M$193.43M$189.89M$94.96M
Income Before Tax Ratio$0.08$0.08$0.09$0.09
Income Tax Expense$49.59M$52.18M$50.37M$25.18M
Net Income$136.98M$141.26M$139.58M$69.79M
Net Income Ratio$0.06$0.06$0.06$0.06
EPS$2.38$2.48$2.45$1.22
Diluted EPS$2.38$2.48$2.45$1.22
Weighted Avg Shares Outstanding$57.49M$56.95M$56.92M$57.03M
Weighted Avg Shares Outstanding (Diluted)$57.60M$56.95M$57.08M$57.08M

Financial performance has remained strong, with revenue growing from $1.08B in Q3 2023 to $2.34B in Q4 2024. Gross profit continued to perform well, with margins at 11% in the latest quarter. Operating income reached $211.19M in Q4 2024, holding a steady 9% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $293.34M. Net income dropped to $136.98M, keeping EPS at $2.38. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;